Giant-cell tumour of bone

M Szendröi - The Journal of Bone & Joint Surgery British …, 2004 - boneandjoint.org.uk
THE JOURNAL OF BONE AND JOINT SURGERY may later also affect the metaphysis. A
GCT starting from the metaphysis has been described in skeletally immature patients at an …

Aneurysmal bone cyst: a review of 52 primary and 16 secondary cases

M Szendröi, I Cser, A Konya… - Archives of orthopaedic …, 1992 - Springer
Authors report on the results of treatment of 52 primary and 16 secondary aneurysmal bone
cysts (ABC). ABC grow rapidly; 84% of them have already destroyed more than the half of …

Osteosarcoma over the age of forty

…, I Meller, M Szendroi, G Folleras, M San-Julian… - European journal of …, 2003 - Elsevier
The European Musculo Skeletal Oncology Society (EMSOS) has carried out a retrospective
review of patients over the age of 40 years with osteosarcoma. 481 patients from 12 centres …

Intraarticular osteoid osteoma: clinical features, imaging results, and comparison with extraarticular localization.

M Szendroi, K Köllo, I Antal, J Lakatos… - The Journal of …, 2004 - jrheum.org
… Temple HT, Vinh TN, Mizel M. Intra-articular osteoid osteoma as a cause of chronic ankle …
Heuck A, Reiser M, Lehner K. Die darstellung des osteoid-osteoms in der MR-tomographie. …

[HTML][HTML] Diagnostic algorithm, prognostic factors and surgical treatment of metastatic cancer diseases of the long bones and spine

M Szendrői, I Antal, A Szendrői, Á Lazáry… - EFORT open …, 2017 - eor.bioscientifica.com
… Toyoda et al 15 and Szendrői et al 20 found a significant difference between synchron and
metachronbone metastases and survival. When the interval between the diagnosis of the first …

CD8+/FOXP3+-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study

…, M Szendroi, AL Bosch, L Bernd, M Csóka… - …, 2015 - Taylor & Francis
Osteosarcoma is the most common primary bone tumor characterized by juvenile onset,
tumor heterogeneity, and early pulmonary metastasis. Therapeutic improvement stagnates …

Good prognosis of localized osteosarcoma in young patients treated with limb‐salvage surgery and chemotherapy

…, I Antal, J Kiss, M Szendroi, M Csoka… - Pediatric blood & …, 2011 - Wiley Online Library
… course of doxorubicin (90 mg/m 2 ), two courses of high-dose methotrexate (12 g/m 2 ), and
two courses of ifosfamide (2 × 3 g/m 2 ) plus cisplatin (120 mg/m 2 ). The surgical decision …

Epigenetic regulation of SMARCB1 By miR‐206, ‐381 and ‐671‐5p is evident in a variety of SMARCB1 immunonegative soft tissue sarcomas, while miR‐765 …

Z Sápi, G Papp, M Szendrői, Z Pápai… - Genes …, 2016 - Wiley Online Library
Complete/partial loss of SMARCB1 nuclear‐immunopositivity is characteristic of a certain
subset of soft tissue sarcomas (STSs). Our previous work showed that oncomiRs‐206,‐381, …

Intraarticular injection of a cross-linked sodium hyaluronate combined with triamcinolone hexacetonide (Cingal) to provide symptomatic relief of osteoarthritis of the …

…, A Ficzere, G Hangody, G Stevens, M Szendroi - Cartilage, 2018 - journals.sagepub.com
… Subjects had a mean age of 58.3 years and a mean BMI of 28.7 kg/m 2 , most were
Caucasian, and more than half (60%) had a KL OA grade of II (Table 1). … Miklos Szendroi

SMARCB1 expression in epithelioid sarcoma is regulated by miR‐206, miR‐381, and miR‐671‐5p on Both mRNA and protein levels

…, T Krausz, TP Stricker, M Szendrői… - Genes …, 2014 - Wiley Online Library
Proximal type epithelioid sarcoma shares similarities with malignant rhabdoid tumor, including
the lack of nuclear immunoreactivity of SMARCB1. Biallelic mutation of SMARCB1 has …